clonidine has been researched along with vanoxerine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, W; van den Buuse, M | 1 |
| Cavalletti, M; Corsini, GU; Fascetti, F; Fornai, F; Tedeschi, D; Vaglini, F | 1 |
| Jinnah, HA; Kasim, S | 1 |
| Banerjee, SK; Katare, PB | 1 |
1 review(s) available for clonidine and vanoxerine
| Article | Year |
|---|---|
Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
Topics: Allopurinol; Aspirin; Bromocriptine; Cardiovascular Diseases; Clonidine; Colesevelam Hydrochloride; Diabetes Mellitus; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Metabolic Syndrome; Piperazines; Tadalafil | 2016 |
3 other study(ies) available for clonidine and vanoxerine
| Article | Year |
|---|---|
Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Clonidine; Desipramine; Dopamine; Dopamine Agents; Haloperidol; Hypertension; Male; Motor Activity; Piperazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1989 |
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetaldehyde; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Ditiocarb; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Kinetics; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nicotine; Piperazines; Selegiline; Serotonin | 1996 |
Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Caffeine; Calcium Channel Agonists; Central Nervous System Stimulants; Clonidine; Dystonia; Lesch-Nyhan Syndrome; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Movement Disorders; Pemoline; Piperazines; Self-Injurious Behavior | 2002 |